The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


AZN  ASTRAZENECA PLC  ORD SHS $0.25

ASTRAZENECA  Currency GBX  Premium Equity Commercial Companies
Company




 Page 3 of 8

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next

Time/Date Code Headline Source Impact
15:58 28-Dec-2012 AZN Director/PDMR Shareholding RNS +1.35% Up
17:56 14-Dec-2012 AZN CRESTOR US Patent Upheld RNS -1.89% Down
14:59 13-Dec-2012 AZN Top-line results of OSKIRA-4 RNS -2.49% Down
14:30 07-Dec-2012 AZN Director/PDMR Shareholding RNS +0.10% Up
14:30 06-Dec-2012 AZN Director/PDMR Shareholding RNS +0.84% Up
15:00 03-Dec-2012 AZN Total Voting Rights RNS +1.93% Up
15:00 03-Dec-2012 AZN Blocklisting Interim Review RNS +1.93% Up
14:30 22-Nov-2012 AZN Director/PDMR Shareholding RNS +2.73% Up
14:30 21-Nov-2012 AZN Director/PDMR Shareholding RNS +2.23% Up
16:30 15-Nov-2012 AZN Director/PDMR Shareholding RNS -1.05% Down
16:49 14-Nov-2012 AZN FORXIGA first in class SGLT2 gets EU approval RNS -1.43% Down
16:30 12-Nov-2012 AZN Definition of Core Financial Measures RNS -1.24% Down
07:00 12-Nov-2012 AZN Top-line phase III results for Naloxegol RNS -1.24% Down
15:00 01-Nov-2012 AZN Total Voting Rights RNS -0.41% Down
13:10 29-Oct-2012 AZN Director/PDMR Shareholding RNS -0.02% Down
13:10 29-Oct-2012 AZN Director/PDMR Shareholding RNS -0.02% Down
07:00 25-Oct-2012 AZN 3rd Quarter Results RNS -0.48% Down
09:00 24-Oct-2012 AZN Notice of Results RNS -0.83% Down
16:30 01-Oct-2012 AZN Total Voting Rights RNS -1.64% Down
14:00 01-Oct-2012 AZN AstraZeneca suspends share repurchase programme RNS -1.64% Down

 Page 3 of 8

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next


ASTRAZENECA - News Analysis

space
space

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds